CFB
FBT icon

Cullen/Frost Bankers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cullen/Frost Bankers’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137
Closed -$27.5K – 1436
2026
Q1 		$27.5K Buy
137
+59
+76% +$12.2K ﹤0.01% 918
2025
Q4 		$16.1K Buy
78
+28
+56% +$5.59K ﹤0.01% 1047
2025
Q3 		$8.96K Buy
+50
New +$8.52K ﹤0.01% 1093
2025
Q1 		– Sell
-90
Closed -$15K – 1349
2024
Q4 		$15K Buy
+90
New +$15.4K ﹤0.01% 820
2023
Q2 		– Sell
-224
Closed -$34.7K – 1178
2023
Q1 		$34.7K Hold
224
– – ﹤0.01% 781
2022
Q4 		$34.5K Buy
+224
New +$33K ﹤0.01% 755

Other funds holding FBT

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Cullen/Frost Bankers's FBT Position: Q2 2026 in Review

Cullen/Frost Bankers sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 137 shares — an estimated $27.5K sold.

Cullen/Frost Bankers first reported a position in FBT in Q4 2022 and held it in 6 quarters. The position peaked at $34.7K in Q1 2023. 210 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Cullen/Frost Bankers reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 137 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $27.5K.
  • Cullen/Frost Bankers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and held it in 6 quarters.
  • Cullen/Frost Bankers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $34.7K in Q1 2023.
  • 210 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.